# EDGAR Filing Document

**Accession Number:** 0000019617
**File Stem:** 0001213900-25-099994
**Filing Date:** 2025-10
**Character Count:** 5717
**Document Hash:** 441296746e75a83e5367bc233609cbb5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-099994.hdr.sgml**: 20251017

**ACCESSION NUMBER**: 0001213900-25-099994

**CONFORMED SUBMISSION TYPE**: 424B3

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251017

**DATE AS OF CHANGE**: 20251017

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-270004
- **FILM NUMBER:** 251401358

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMorgan Chase Financial Co. LLC
- **CENTRAL INDEX KEY:** 0001665650
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 475462128
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-270004-01
- **FILM NUMBER:** 251401359

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **STREET 2:** FLOOR 21
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179
- **BUSINESS PHONE:** (212) 270-6000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **STREET 2:** FLOOR 21
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10179

Filed Pursuant to Rule 424(b)(3)

Registration Statement Nos. 333-270004 and 333-270004-01

Amendment No. 1 to the [Pricing Supplement](https://www.sec.gov/Archives/edgar/data/19617/000121390025084873/ea0256205-01_424b2.htm) dated September 3, 2025 [the Prospectus and Prospectus Supplement, each dated April 13, 2023](http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf), [the Product Supplement No. 4-I dated April 13, 2023](http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf) and [the Prospectus Addendum dated June 3, 2024](http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm)

JPMorgan Chase Financial Company LLC

Medium-Term Notes, Series A<br> Digital Equity Notes due 2026

(Linked to the Class A Common Stock of Coinbase Global, Inc.)

Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.

As described in the pricing supplement dated September 3, 2025 related to the notes referred to above with the CUSIP and ISIN referred to below (the "pricing supplement"), the initial underlier level is the lowest closing level of the underlier during the observation period, which ended on October 3, 2025. Accordingly, the initial underlier level has been determined and is as follows:

**Initial underlier level:** the lowest closing level of the underlier during the observation period, which was $299.07 (the closing level of the underlier on September 5, 2025)

**CUSIP no.:** 48136GNX4

**ISIN no.:** US48136GNX42

***Your investment in the notes involves certain risks, including, among other things, our credit risk. See "Risk Factors" on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" on page PS-11 of the accompanying product supplement and "Selected Risk Factors" on page PS-12 of the pricing supplement.***

**Neither the Securities and Exchange Commission (the "SEC") nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this amendment, the pricing supplement, the accompanying product supplement, the accompanying prospectus supplement, the accompanying prospectus or the accompanying prospectus addendum. Any representation to the contrary is a criminal offense.**

**The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.**

**You should read this amendment together with the pricing supplement and the accompanying product supplement, prospectus supplement, prospectus and prospectus addendum, each of which can be accessed via the hyperlinks below.**

· Pricing Supplement dated September 3, 2025:

[http://www.sec.gov/Archives/edgar/data/19617/000121390025084873/ea0256205-01_424b2.htm](http://www.sec.gov/Archives/edgar/data/19617/000121390025084873/ea0256205-01_424b2.htm)

· Product supplement no. 4-I dated April 13, 2023:

[http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf](http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf)

· Prospectus supplement and prospectus, each dated April 13, 2023:

[http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf](http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf)

● Prospectus addendum dated June 3, 2024:

[http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm](http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm)

Amendment No. 1 dated October 17, 2025